title: Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.
abstract: The incidence of human Campylobacter infections is increasing worldwide, as well as the proportion of isolates resistant to fluoroquinolones and/or macrolides, the drugs of choice to treat campylobacteriosis. In this review, we report recent developments in the understanding of the resistance mechanisms to fluoroquinolones and macrolides. In addition, we will discuss the recent findings on multidrug resistance in Campylobacter spp.
authors.affiliation: Institut National de la Recherche Agronomique, UR086 BioAgresseurs, Santé, Environnement, Nouzilly, France. payot@tours.inra.fr
authors.forename: Sophie
authors.initials: S
authors.lastname: Payot
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Bolla
authors.forename: Deborah
authors.initials: D
authors.lastname: Corcoran
authors.forename: Séamus
authors.initials: S
authors.lastname: Fanning
authors.forename: Francis
authors.initials: F
authors.lastname: Mégraud
authors.forename: Qijing
authors.initials: Q
authors.lastname: Zhang
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects* / Q000235:genetics; D002169:Campylobacter Infections / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D018942:Macrolides